Status:

UNKNOWN

Acceptability of Identifying and Managing Psychological Distress in Inflammatory Bowel Disease: the COMPASS-IBD Study

Lead Sponsor:

King's College London

Collaborating Sponsors:

Guy's and St Thomas' NHS Foundation Trust

Crohn's and Colitis UK

Conditions:

IBD

Psychological Distress

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study is a single-centre, interventional implementation and feasibility study. Patients in the IBD service will be able to access COMPASS, an online cognitive-behavioural therapy (CBT) programme...

Eligibility Criteria

Inclusion

  • PATIENT PARTICIPANTS
  • Aged 18 or over
  • Have an IBD diagnosis
  • Have English proficiency
  • Have access to a computer
  • Have mild to moderate symptoms of depression and/or anxiety (PHQ-9 score 5-19 and/or GAD-7 score 5-14, or PHQ-ADS score 10-29) or severe depression and/or anxiety (PHQ-9 score≥20 and/or GAD-7 score ≥15, or PHQ-ADS score ≥30 but no acute suicidal risk) and awaiting treatment from clinical psychologist as specified above.
  • Have evidence of illness-related distress

Exclusion

  • Evidence of substance dependency, cognitive impairment, severe mental health conditions
  • Evidence of acute suicidal risk PHQ-9 item-9 \>1 and recent serious suicidal intent and/or planning
  • Are receiving current psychological treatment or are on a wait-list to receive treatment within the study period (next 6 months)
  • Have depression and/or anxiety unrelated to IBD (e.g. where disease long-standing/well-controlled unrelated to current presentation of distress)
  • HEALTHCARE PROFESSIONAL PARTICIPANTS
  • Work in the Gastroenterology IBD service at Guy's and St Thomas' Hospitals NHS Trust (GSTT).
  • Have experience of either: i) Utilising the routine mental health screening tools ii) Assessing and triaging patients onto the COMPASS programme and/or iii) Providing therapist support to the users of COMPASS.

Key Trial Info

Start Date :

December 2 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 29 2024

Estimated Enrollment :

108 Patients enrolled

Trial Details

Trial ID

NCT05330299

Start Date

December 2 2022

End Date

February 29 2024

Last Update

December 13 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Health Psychology Section

London, United Kingdom, SE1 9RT

Acceptability of Identifying and Managing Psychological Distress in Inflammatory Bowel Disease: the COMPASS-IBD Study | DecenTrialz